Atherectomy devices market to reach $1.54 billion by 2030

The atherectomy devices market is projected to grow from $1.01 billion in 2025 to $1.54 billion by 2030, driven by rising cardiovascular disease, more minimally invasive procedures and expanding use in complex calcified lesions. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through 2030.

Why it matters: - Atherectomy devices are used to remove plaque from blood vessels in minimally invasive procedures. - The market is tied to treatment of peripheral artery disease and coronary artery disease, where restoring blood flow can reduce symptoms and avoid more invasive surgery. - Growth in the market reflects rising demand for advanced cardiovascular care as patient volumes increase.

What happened: - The Business Research Company said the global atherectomy devices market is expected to rise from $1.01 billion in 2025 to $1.11 billion in 2026. - The same analysis projects the market will reach $1.54 billion by 2030. - The report puts the market's 2025-2026 CAGR at 9.6% and the 2026-2030 CAGR at 8.6%. - The company published a free sample report and a full market report online, with links provided in the release. - Free sample report - Full market report

The details: - The report points to rising peripheral artery disease, broader use of minimally invasive plaque removal, more hospital-based coronary interventions and the growth of specialized vascular centers as drivers of earlier market growth. - Looking ahead, demand is expected to rise for advanced plaque modification tools and devices that treat complex calcified lesions. - Investment in next-generation device designs and materials is also expected to support growth. - Expansion of outpatient and ambulatory vascular procedures is another growth factor. - The report says image-guided endovascular therapies are gaining traction. - Key trends include atherectomy use in PAD and CAD, development of specialized systems for peripheral, coronary and neurovascular applications, and more precise plaque debulking to improve vessel patency and lower restenosis risk. - The market is also seeing more combined use of atherectomy with angioplasty and stenting for complex arterial blockages. - Multi-technology portfolios now include rotational, orbital, directional and laser systems. - Atherectomy devices are described as specialized medical tools used to remove atherosclerotic plaque from blood vessels.

Between the lines: - The report's growth case depends heavily on the rising burden of coronary artery disease and the shift toward less invasive interventions. - The clinical push is toward targeted plaque removal, which can help physicians treat harder lesions while trying to reduce repeat narrowing of the vessel. - North America's lead suggests a market shaped by mature healthcare systems and faster adoption of newer cardiovascular technologies. - Asia-Pacific's expected growth points to widening access and higher spending on cardiovascular treatment across more markets. - In May 2024, the Singapore Heart Foundation reported 8,311 cardiovascular-related deaths in 2023, up from the prior year, and said atherosclerosis accounted for 60% of cardiovascular deaths in 2023, up from 59% in 2022.

What's next: - The market is expected to keep expanding as hospitals and outpatient centers adopt more minimally invasive plaque removal procedures. - Future growth will likely hinge on new device designs, wider image-guided therapies and continued use in complex calcified lesions. - The report expects North America to remain the largest regional market in 2025, with Asia-Pacific posting the fastest growth through the forecast period.

The bottom line: - Atherectomy devices are moving from a niche interventional tool to a broader cardiovascular treatment platform as demand rises for precise, minimally invasive plaque removal.